PCDH10 is a candidate tumour suppressor gene in medulloblastoma

Child's Nervous System

Volumn 27, Issue 8, 2011, Pages 1243-1249

  Bertrand, Kelsey C ^a,b   MacK, Stephen C ^a,b   Northcott, Paul A ^a   Garzia, Livia ^a   Dubuc, Adrian ^a,b   Pfister, Stefan M ^c,d   Rutka, James T ^a,b   Weiss, William A ^e   Taylor, Michael D ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; DNA methylation; Medulloblastoma; Metastases; PCDH10

Indexed keywords

ARTICLE; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GENE CONTROL; GENE DELETION; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

CADHERINS; CELL MOVEMENT; CELL PROLIFERATION; CEREBELLAR NEOPLASMS; DNA METHYLATION; DOWN-REGULATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENES, TUMOR SUPPRESSOR; HUMANS; MEDULLOBLASTOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79960920287     PISSN: 02567040     EISSN: 14330350     Source Type: Journal    
DOI: 10.1007/s00381-011-1486-x     Document Type: Article

References (32)

1. R Beroukhim G Getz L Nghiemphu J Barretina T Hsueh D Linhart I Vivanco JC Lee JH Huang S Alexander J Du T Kau RK Thomas K Shah H Soto S Perner J Prensner RM Debiasi F Demichelis C Hatton MA Rubin LA Garraway SF Nelson L Liau PS Mischel TF Cloughesy M Meyerson TA Golub ES Lander IK Mellinghoff WR Sellers 2007 Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma Proc Natl Acad Sci USA 104 20007 20012 18077431 10.1073/pnas.0710052104 1:CAS:528:DC%2BD1cXhs1WmtQ%3D%3D
2. YJ Cho A Tsherniak P Tamayo S Santagata A Ligon H Greulich R Berhoukim V Amani L Goumnerova CG Eberhart CC Lau JM Olson RJ Gilbertson A Gajjar O Delattre M Kool K Ligon M Meyerson JP Mesirov SL Pomeroy 2010 Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome J Clin Oncol 29 11 1424 1430 21098324 10.1200/JCO.2010.28.5148
3. DW Ellison SC Clifford A Gajjar RJ Gilbertson 2003 What's new in neuro-oncology? Recent advances in medulloblastoma Eur J Paediatr Neurol 7 53 66 12697428 10.1016/S1090-3798(03)00014-X (Pubitemid 36519473)
4. A Gajjar R Hernan M Kocak C Fuller Y Lee PJ McKinnon D Wallace C Lau M Chintagumpala DM Ashley SJ Kellie L Kun RJ Gilbertson 2004 Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma J Clin Oncol 22 984 993 14970185 10.1200/JCO.2004.06.032 1:CAS:528:DC%2BD2cXptlCkurs%3D (Pubitemid 41095029)
5. L Lafay-Cousin E Bouffet C Hawkins A Amid A Huang DJ Mabbott 2009 Impact of radiation avoidance on survival and neurocognitive outcome in infant medulloblastoma Curr Oncol 16 21 28 20016743 10.3747/co.v16i6.435 1:STN:280:DC%2BD1MfjtVyrtw%3D%3D
6. CJ Lin HC Lai KH Wang CA Hsiung HW Liu DC Ding CY Hsieh TY Chu 2011 Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results Am J Obstet Gynecol 204 21 e21 e27
7. DJ Mabbott MD Noseworthy E Bouffet C Rockel S Laughlin 2006 Diffusion tensor imaging of white matter after cranial radiation in children for medulloblastoma: correlation with IQ Neuro Oncology 8 244 252 16723629 10.1215/15228517-2006-002 (Pubitemid 46542649)
8. DJ Mabbott M Barnes N Laperriere SH Landry E Bouffet 2007 Neurocognitive function in same-sex twins following focal radiation for medulloblastoma Neuro Oncology 9 460 464 17704358 10.1215/15228517-2007-028
9. TG Mainprize MD Taylor JT Rutka 2000 Pediatric brain tumors: a contemporary prospectus Clin Neurosurg 47 259 302 11197707 1:STN:280: DC%2BD3M7kslSktw%3D%3D
10. TG Mainprize MD Taylor JT Rutka 2000 Perspectives in pediatric neurosurgery Childs Nerv Syst 16 809 820 11151735 10.1007/s003810000345 1:STN:280:DC%2BD3M7lt12ltg%3D%3D
11. K Miyamoto T Fukutomi S Akashi-Tanaka T Hasegawa T Asahara T Sugimura T Ushijima 2005 Identification of 20 genes aberrantly methylated in human breast cancers Int J Cancer 116 407 414 15818620 10.1002/ijc.21054 1:CAS:528: DC%2BD2MXmtl2kur8%3D (Pubitemid 40993337)
12. PJ Morin 1999 Beta-catenin signaling and cancer Bioessays 21 1021 1030 10580987 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P 1:STN:280:DC%2BD3c%2FkslOiuw%3D%3D
13. G Narayan L Scotto V Neelakantan SH Kottoor AH Wong SL Loke M Mansukhani B Pothuri JD Wright AM Kaufmann A Schneider H Arias-Pulido Q Tao VV Murty 2009 Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer Genes Chromosom Cancer 48 983 992 19681120 10.1002/gcc.20703 1:CAS:528:DC%2BD1MXhtFGjtrbI
14. D Ng T Stavrou L Liu MD Taylor B Gold M Dean MJ Kelley EC Dubovsky G Vezina HS Nicholson J Byrne JT Rutka D Hogg GH Reaman AM Goldstein 2005 Retrospective family study of childhood medulloblastoma Am J Med Genet A 134 399 403 15759260 (Pubitemid 40604066)
15. PA Northcott LA Fernandez JP Hagan DW Ellison W Grajkowska Y Gillespie R Grundy T Van Meter JT Rutka CM Croce AM Kenney MD Taylor 2009 The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors Cancer Res 69 3249 3255 19351822 10.1158/0008-5472.CAN-08-4710 1:CAS:528: DC%2BD1MXksV2hs7s%3D
16. PA Northcott Y Nakahara X Wu L Feuk DW Ellison S Croul S Mack PN Kongkham J Peacock A Dubuc YS Ra K Zilberberg J McLeod SW Scherer J Sunil Rao CG Eberhart W Grajkowska Y Gillespie B Lach R Grundy IF Pollack RL Hamilton T Van Meter CG Carlotti F Boop D Bigner RJ Gilbertson JT Rutka MD Taylor 2009 Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma Nat Genet 41 465 472 19270706 10.1038/ng.336 1:CAS:528:DC%2BD1MXivVKntro%3D
17. PA Northcott A Korshunov H Witt T Hielscher CG Eberhart S Mack E Bouffet SC Clifford CE Hawkins P French JT Rutka S Pfister MD Taylor 2010 Medulloblastoma comprises four distinct molecular variants J Clin Oncol 29 11 1408 1414 20823417 10.1200/JCO.2009.27.4324
18. PA Northcott JT Rutka MD Taylor 2010 Genomics of medulloblastoma: from Giemsa-banding to next-generation sequencing in 20 years Neurosurg Focus 28 E6 20043721 10.3171/2009.10.FOCUS09218
19. Y Oki HM Kantarjian V Gharibyan D Jones S O'Brien S Verstovsek J Cortes GM Morris G Garcia-Manero JP Issa 2007 Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia Cancer 109 899 906 17236224 10.1002/cncr.22470 1:CAS:528:DC%2BD2sXjsVKnsL8%3D (Pubitemid 46333532)
20. Y Oki J Jelinek L Shen HM Kantarjian JP Issa 2008 Induction of hypomethylation and molecular response after decitabine therapy in patients with chronic myelomonocytic leukemia Blood 111 2382 2384 18055864 10.1182/blood-2007-07-103960 1:CAS:528:DC%2BD1cXisVeitLc%3D (Pubitemid 351451448)
21. SL Palmer T Hassall K Evankovich DJ Mabbott M Bonner C Deluca R Cohn MJ Fisher EB Morris A Broniscer A Gajjar 2010 Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma Neuro Oncology 12 1311 1317 20713408
22. DJ Stewart JP Issa R Kurzrock MI Nunez J Jelinek D Hong Y Oki Z Guo S Gupta II Wistuba 2009 Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomas Clin Cancer Res 15 3881 3888 19470736 10.1158/1078-0432.CCR-08-2196 1:CAS:528:DC%2BD1MXmsFOju7g%3D
23. U Tabori B Baskin M Shago N Alon MD Taylor PN Ray E Bouffet D Malkin C Hawkins 2010 Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations J Clin Oncol 28 1345 1350 20142599 10.1200/JCO.2009.23. 5952 1:CAS:528:DC%2BC3cXksFSqtbY%3D
24. MS Tamber K Bansal ML Liang TG Mainprize B Salhia P Northcott M Taylor JT Rutka 2006 Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies Childs Nerv Syst 22 1379 1394 16951964 10.1007/s00381-006-0187-3 (Pubitemid 44650671)
25. MD Taylor TG Mainprize JT Rutka 2000 Molecular insight into medulloblastoma and central nervous system primitive neuroectodermal tumor biology from hereditary syndromes: a review Neurosurgery 47 888 901 11014429 10.1097/00006123-200010000-00020 1:STN:280:DC%2BD3cvmt1ekug%3D%3D (Pubitemid 32103665)
26. MD Taylor TG Mainprize JT Rutka L Becker J Bayani JM Drake 2001 Medulloblastoma in a child with Rubenstein-Taybi Syndrome: case report and review of the literature Pediatr Neurosurg 35 235 238 11741116 10.1159/000050428 1:STN:280:DC%2BD3MnpsVemsQ%3D%3D (Pubitemid 34008796)
27. MD Taylor L Liu C Raffel CC Hui TG Mainprize X Zhang R Agatep S Chiappa L Gao A Lowrance A Hao AM Goldstein T Stavrou SW Scherer WT Dura B Wainwright JA Squire JT Rutka D Hogg 2002 Mutations in SUFU predispose to medulloblastoma Nat Genet 31 306 310 12068298 10.1038/ng916 1:CAS:528:DC%2BD38XkvVGmtLY%3D
28. MD Taylor X Zhang L Liu CC Hui TG Mainprize SW Scherer B Wainwright D Hogg JT Rutka 2004 Failure of a medulloblastoma-derived mutant of SUFU to suppress WNT signaling Oncogene 23 4577 4583 15077159 10.1038/sj.onc.1207605 1:CAS:528:DC%2BD2cXksV2gsrg%3D (Pubitemid 38850405)
29. MC Thompson C Fuller TL Hogg J Dalton D Finkelstein CC Lau M Chintagumpala A Adesina DM Ashley SJ Kellie MD Taylor T Curran A Gajjar RJ Gilbertson 2006 Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations J Clin Oncol 24 1924 1931 16567768 10.1200/JCO.2005.04.4974 1:CAS:528:DC%2BD28XkvVajtbY%3D (Pubitemid 46638992)
30. AS Yap 1998 The morphogenetic role of cadherin cell adhesion molecules in human cancer: a thematic review Cancer Investig 16 252 261 10.3109/ 07357909809039774 1:CAS:528:DyaK1cXjtF2msro%3D (Pubitemid 28211011)
31. J Ying H Li TJ Seng C Langford G Srivastava SW Tsao T Putti P Murray AT Chan Q Tao 2006 Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation Oncogene 25 1070 1080 16247458 10.1038/sj.onc.1209154 1:CAS:528:DC%2BD28XhsVehsrY%3D (Pubitemid 43277014)
32. B Yu H Yang C Zhang Q Wu Y Shao J Zhang M Guan J Wan W Zhang 2010 High-resolution melting analysis of PCDH10 methylation levels in gastric, colorectal and pancreatic cancers Neoplasma 57 247 252 20353276 10.4149/neo-2010-03-247 1:CAS:528:DC%2BC3cXnt1yrsLs%3D